Literature DB >> 22300138

Emerging roles of microRNA-22 in human disease and normal physiology.

J Xiong1.   

Abstract

MicroRNAs (miRNAs) are an abundant class of small noncoding RNAs that have critical regulatory functions in various biological processes. MicroRNA-22 (miR-22) is a highly-conserved 22-nt miRNA, whose roles in human diseases and normal physiology are just beginning to emerge. Recently, miR-22 has been connected to a great number of activities that encompass tumorigenesis, epigenetic modification, embryonic development, skeletal metabolism, panic disorder, and cardiomyocyte hypertrophy. Aberrant expression of miR-22 has been identified in multiple human diseases. Here, we describe our current understanding of the roles of miR-22 and its signaling circuitry in pathology and physiology, and discuss important advances that set the scene for applying miR-22 to the prevention and treatment of a wide range of human diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22300138     DOI: 10.2174/156652412799218886

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  19 in total

1.  Activation of the PI3K/AKT pathway by microRNA-22 results in CLL B-cell proliferation.

Authors:  F Palacios; C Abreu; D Prieto; P Morande; S Ruiz; T Fernández-Calero; H Naya; G Libisch; C Robello; A I Landoni; R Gabus; G Dighiero; P Oppezzo
Journal:  Leukemia       Date:  2014-05-14       Impact factor: 11.528

2.  MiR-22 regulated T cell differentiation and hepatocellular carcinoma growth by directly targeting Jarid2.

Authors:  Lian Zhang; Ping Yang; Jing Wang; Qi Liu; Tian Wang; Yaling Wang; Feng Lin
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

3.  Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis.

Authors:  Shuang-Zheng Jia; Yunpeng Yang; Jinghe Lang; Pengran Sun; Jinhua Leng
Journal:  Hum Reprod       Date:  2012-11-30       Impact factor: 6.918

Review 4.  MicroRNA regulation and role in stem cell maintenance, cardiac differentiation and hypertrophy.

Authors:  K T Kuppusamy; H Sperber; H Ruohola-Baker
Journal:  Curr Mol Med       Date:  2013-06       Impact factor: 2.222

5.  Effects of miR-22 on viability, migration, invasion and apoptosis in retinoblastoma Y79 cells by targeting high-mobility group box 1.

Authors:  Min Liu; Shuo-Min Wang; Zheng-Xuan Jiang; Hennein Lauren; Li-Ming Tao
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

6.  Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.

Authors:  Nina A Sibbesen; Katharina L Kopp; Ivan V Litvinov; Lars Jønson; Andreas Willerslev-Olsen; Simon Fredholm; David L Petersen; Claudia Nastasi; Thorbjørn Krejsgaard; Lise M Lindahl; Robert Gniadecki; Nigel P Mongan; Denis Sasseville; Mariusz A Wasik; Lars Iversen; Charlotte M Bonefeld; Carsten Geisler; Anders Woetmann; Niels Odum
Journal:  Oncotarget       Date:  2015-08-21

7.  Microarray analysis of transcriptome of medulla identifies potential biomarkers for Parkinson's disease.

Authors:  Xiao-Yang Liao; Wei-Wen Wang; Zheng-Hui Yang; Jun Wang; Hang Lin; Qing-Song Wang; Yu-Xian Wu; Yu Liu
Journal:  Int J Genomics       Date:  2013-11-20       Impact factor: 2.326

Review 8.  Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision Medicine.

Authors:  Vittorio Simeon; Katia Todoerti; Francesco La Rocca; Antonella Caivano; Stefania Trino; Marta Lionetti; Luca Agnelli; Luciana De Luca; Ilaria Laurenzana; Antonino Neri; Pellegrino Musto
Journal:  Int J Mol Sci       Date:  2015-07-30       Impact factor: 5.923

9.  High-throughput sequencing reveals differential expression of miRNAs in intestine from sea cucumber during aestivation.

Authors:  Muyan Chen; Xiumei Zhang; Jianning Liu; Kenneth B Storey
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

10.  ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC).

Authors:  Shujuan Pan; Xiaoyun Cheng; Hongan Chen; Patricia D Castro; Michael M Ittmann; Anne W Hutson; Susan K Zapata; Richard N Sifers
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.